<DOC>
	<DOCNO>NCT02945462</DOCNO>
	<brief_summary>Recovery erectile function use bone marrow mesenchymal stem cell ( MSCs ) vitro expansion restrict culturing condition .</brief_summary>
	<brief_title>Bone Marrow Mesenchymal Stem Cells Erectile Dysfunction ( ED )</brief_title>
	<detailed_description>Four diabetic male patient range 25-65 year diagnose erectile dysfunction select . This diagnosis base medical history , validated questionnaire , physical examination , laboratory test specific diagnostic test . Patients evidence untreated hypogonadism , current urinary tract bladder infection , clinically evident penile anatomical deformity , previous penile implant penile vascular surgery , uncontrolled hypertension hypotension , report unstable Cardiovascular disease , uncontrolled diabetes ( HbA1c &gt; 10 % ) , primary hyperlipidemia exclude . The investigator hypothesize intracavernous injection stem cell facilitate recovery erectile function result satisfy clinical outcome patient . This study perform : 1 . To test safety autologous intracavernous bone marrow mesenchymal stem cell . 2 . To evaluate benefit patient concern recovery natural erection perform detail specific diagnostic test prior post MSCs injection team Jordan University Hospital Cell Therapy Center Jordan University . 3 . To study feasibility , indication criterion application modality Bone marrow mesenchymal stem cell wider study .</detailed_description>
	<mesh_term>Erectile Dysfunction</mesh_term>
	<criteria>1 . Adult male patient range 25 65 year . 2 . Type 1 type 2 diabetic patient personal history diabetes ≥ 5 year . 3 . History chronic erectile dysfunction least six month . 4 . HbA1c ≤ 10 % . 5 . Baseline International Index Erectile Function ( IIEF ) score &lt; 26 . 6 . Not interested able use Phosphodiesterase type 5 inhibitor ( PDE5i ) drug therapy willing forgo treatment first 6 month period follow study treatment . 7 . Body mass index 20 30 . 8 . Willing provide write informed consent , complete questionnaire , available baseline treatment follow examination require protocol . 1 . Untreated hypogonadism low serum total testosterone &lt; 200 ng/dl . 2 . Current urinary tract bladder infection . 3 . Any medical evidence infectious disease . 4 . Clinically evident penile anatomical deformity ( e.g. , Peyronie 's disease ) history priapism . 5 . Skin irritation , infection , wound , sore disruption immediate area skin entry penile injection . 6 . Current previous malignancy . 7 . Patients primary hyperlipidemia . 8 . Use non study treatment erectile dysfunction within 4 week study treatment . 9 . Lack willingness continue 6 month study treatment . 10 . Any previous penile implant penile vascular surgery . 11 . Uncontrolled hypertension hypotension ( systolic blood pressure &gt; 170 &lt; 90 mm Hg , diastolic blood pressure &gt; 100 &lt; 50 mm Hg ) . 12 . Reported unstable cardiovascular disease ( e.g. , unstable angina , myocardial infarction within past 6 month , cardiac failure lifethreatening arrhythmia , congestive heart failure ) symptomatic postural hypotension within 6 month screen . 13 . Bleeding clot disorder , use anticoagulant therapy . 14 . Lab value complete blood count , prothrombin time/ partial thromboplastin time/international randomize ratio ( PT/PTT/INR ) , Aspartate aminotransferase ( AST ) , alanine aminotransferase ( ALT ) , creatinine fall outside normal lab value . 15 . Systemic autoimmune disorder . 16 . Significant active systemic localize infection . 17 . Receiving immunosuppressant medication . 18 . HbA1c &gt; 10 % .</criteria>
	<gender>Male</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>